Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
According to the latest research, the global High-flow Nasal Cannula market size was valued at USD 3114.74 million in 2022 and is expected to expand at a CAGR of 4.1% during the forecast period, reaching USD 3963.92 million by 2028.
High-flow nasal cannula (HFNC) oxygen therapy is carried out using an air/oxygen blender, active humidifier, single heated tube, and nasal cannula. Able to deliver adequately heated and humidified medical gas at flows up to 60 L/min, it is considered to have a number of physiological advantages compared with other standard oxygen therapies, including reduced anatomical dead space, PEEP, constant FIO2, and good humidification.
Influence of COVID-19 Outbreak on High-flow Nasal Cannula Industry Development
Market demand increases
In recent years, High-flow Nasal Cannula has been rapidly popularized in clinical practice, and its clinical efficacy has been widely recognized by clinicians. In recent years, many prospective clinical studies with large samples have been published in famous international journals, which proves the therapeutic value of High-flow Nasal Cannula equipment in hypoxemia and mild to moderate simple hypoxic respiratory failure (type I respiratory failure).
Compared with traditional oxygen therapy, high-flow nasal canula (HFNC) has great advantages in acute hypoxic respiratory failure, which can reduce the intubation rate and 90-day mortality, and has played an important role in the treatment of MERS-CoV pneumonia and H1N1 pneumonia.
At present, HFNC also plays an important role in the treatment of severe and critical patients in novel coronavirus (NCP).
Therefore, high-flow nasal Cannula industry equipment is an urgent product to deal with the epidemic. Resulting in increasing demand in downstream market.
Supply of raw materials is tight
Affected by COVID-19, the logistics speed in most areas slowed down, and the supply of raw materials in the high-flow nasal cannula industry was tight. The downstream demand increased, and the supply of raw materials was relatively insufficient, which greatly affected the production of related enterprises in the hardest hit areas. Short-term epidemic has little impact on raw material supply of enterprises, mainly consuming inventory materials, while long-term epidemic will cause incalculable losses. If the epidemic develops further, the logistics will always be unsatisfactory, and small and medium-sized enterprises with high-flow nasal cannula will probably close down due to insufficient supply of raw materials, and even large enterprises will face the same problem.
Market Driver Analysis
Increased downstream demand High-Flow Nasal Cannula has the functions of reducing inhalation resistance, flushing nasopharyngeal anatomy dead space, reducing metabolic work related to gas regulation, improving airway conductivity and mucosal ciliary clearance, and providing low levels of positive airway pressure. And widely used in respiratory diseases and chronic lung diseases. Because the newborn's respiratory organs and functions are immature, it is also a high incidence stage of respiratory diseases. A common respiratory disease in newborns is neonatal pneumonia. The worldwide spread of COVID-19 in recent two years has also increased the demand for high-flow nasal cannula. Secondly, with the development of technology, the High-Flow Nasal Cannula equipment will be more complete and can meet more needs. Therefore, the increase in respiratory diseases and the development of new technologies are one of the important factors driving the global market for high-flow nasal cannula.
Health industry development People's health awareness has been enhanced and medical systems in various countries have been continuously improved, and policies related to medical security have also benefited the market. In most developed countries and some developing countries, universal health insurance has either been achieved or is a policy that governments of various countries are pushing hard. At the same time, the COVID-19 epidemic has brought great pressure on the labor force, infrastructure and supply chain of the global medical industry, and exposed the problem of unequal social medical resources. At the same time, it accelerates the change of industry ecosystem, forcing public and private medical systems to adapt and innovate in a short time. People's awareness of health is also rising. In addition, the developing healthcare industry in Asia is creating better opportunities for important market participants to expand their business. It is expected that emerging markets in Asia Pacific will have a positive impact on market growth in the forecast year.
Region Overview:
North America had the highest growth rate of all regions.
Company Overview:
Fisher & Paykel Healthcare is one of the major players operating in the High-flow Nasal Cannula market, holding a share of 24.34% in 2021.
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company's products are sold in more than 120 countries worldwide.
ResMed pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. ResMed cloud-connected medical devices transform care for people with sleep apnea, COPD and other chronic diseases. ResMed comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, ResMed improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.
Segmentation Overview:
By type, Nasal Cannulas segment accounted for the largest share of market in 2021.
Application Overview:
By application, the Hospitals segment occupied the biggest share from 2017 to 2022.
This report elaborates on the market size, market characteristics, and market growth of the High-flow Nasal Cannula industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of High-flow Nasal Cannula. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global High-flow Nasal Cannula Market Report Include:
Market Size Estimates: High-flow Nasal Cannula market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: High-flow Nasal Cannula market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the High-flow Nasal Cannula market
Segment Market Analysis: High-flow Nasal Cannula market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: High-flow Nasal Cannula market situations and prospects in major and top regions and countries
High-flow Nasal Cannula Market
High-flow Nasal Cannula Industry Chain: High-flow Nasal Cannula market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
High-flow Nasal Cannula Industry News, Policies by regions
High-flow Nasal Cannula Industry Porters Five Forces Analysis
Key players in the global High-flow Nasal Cannula market are covered in Chapter 2:
Salter Labs
Teleflex Incorporated
TNI Medical AG
Flexicare Medical Limited
Fisher & Paykel Healthcare
ResMed
Great Group Medical
Vyaire Medical
Hamilton Medical
Koninklijke Philips
Vapotherm
In Chapter 6 and Chapter 9, on the basis of types, the High-flow Nasal Cannula market from 2018 to 2028 is primarily split into:
Air/Oxygen Blender
Nasal Cannulas
Active Humidifier
Single Heated Tube
Others
In Chapter 7 and Chapter 10, on the basis of applications, the High-flow Nasal Cannula market from 2018 to 2028 covers:
Hospitals
Clinics
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global High-flow Nasal Cannula market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the High-flow Nasal Cannula industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of High-flow Nasal Cannula market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the High-flow Nasal Cannula industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on High-flow Nasal Cannula market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the High-flow Nasal Cannula market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed High-flow Nasal Cannula market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
High-flow nasal cannula (HFNC) oxygen therapy is carried out using an air/oxygen blender, active humidifier, single heated tube, and nasal cannula. Able to deliver adequately heated and humidified medical gas at flows up to 60 L/min, it is considered to have a number of physiological advantages compared with other standard oxygen therapies, including reduced anatomical dead space, PEEP, constant FIO2, and good humidification.
Influence of COVID-19 Outbreak on High-flow Nasal Cannula Industry Development
Market demand increases
In recent years, High-flow Nasal Cannula has been rapidly popularized in clinical practice, and its clinical efficacy has been widely recognized by clinicians. In recent years, many prospective clinical studies with large samples have been published in famous international journals, which proves the therapeutic value of High-flow Nasal Cannula equipment in hypoxemia and mild to moderate simple hypoxic respiratory failure (type I respiratory failure).
Compared with traditional oxygen therapy, high-flow nasal canula (HFNC) has great advantages in acute hypoxic respiratory failure, which can reduce the intubation rate and 90-day mortality, and has played an important role in the treatment of MERS-CoV pneumonia and H1N1 pneumonia.
At present, HFNC also plays an important role in the treatment of severe and critical patients in novel coronavirus (NCP).
Therefore, high-flow nasal Cannula industry equipment is an urgent product to deal with the epidemic. Resulting in increasing demand in downstream market.
Supply of raw materials is tight
Affected by COVID-19, the logistics speed in most areas slowed down, and the supply of raw materials in the high-flow nasal cannula industry was tight. The downstream demand increased, and the supply of raw materials was relatively insufficient, which greatly affected the production of related enterprises in the hardest hit areas. Short-term epidemic has little impact on raw material supply of enterprises, mainly consuming inventory materials, while long-term epidemic will cause incalculable losses. If the epidemic develops further, the logistics will always be unsatisfactory, and small and medium-sized enterprises with high-flow nasal cannula will probably close down due to insufficient supply of raw materials, and even large enterprises will face the same problem.
Market Driver Analysis
Increased downstream demand High-Flow Nasal Cannula has the functions of reducing inhalation resistance, flushing nasopharyngeal anatomy dead space, reducing metabolic work related to gas regulation, improving airway conductivity and mucosal ciliary clearance, and providing low levels of positive airway pressure. And widely used in respiratory diseases and chronic lung diseases. Because the newborn's respiratory organs and functions are immature, it is also a high incidence stage of respiratory diseases. A common respiratory disease in newborns is neonatal pneumonia. The worldwide spread of COVID-19 in recent two years has also increased the demand for high-flow nasal cannula. Secondly, with the development of technology, the High-Flow Nasal Cannula equipment will be more complete and can meet more needs. Therefore, the increase in respiratory diseases and the development of new technologies are one of the important factors driving the global market for high-flow nasal cannula.
Health industry development People's health awareness has been enhanced and medical systems in various countries have been continuously improved, and policies related to medical security have also benefited the market. In most developed countries and some developing countries, universal health insurance has either been achieved or is a policy that governments of various countries are pushing hard. At the same time, the COVID-19 epidemic has brought great pressure on the labor force, infrastructure and supply chain of the global medical industry, and exposed the problem of unequal social medical resources. At the same time, it accelerates the change of industry ecosystem, forcing public and private medical systems to adapt and innovate in a short time. People's awareness of health is also rising. In addition, the developing healthcare industry in Asia is creating better opportunities for important market participants to expand their business. It is expected that emerging markets in Asia Pacific will have a positive impact on market growth in the forecast year.
Region Overview:
North America had the highest growth rate of all regions.
Company Overview:
Fisher & Paykel Healthcare is one of the major players operating in the High-flow Nasal Cannula market, holding a share of 24.34% in 2021.
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company's products are sold in more than 120 countries worldwide.
ResMed pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. ResMed cloud-connected medical devices transform care for people with sleep apnea, COPD and other chronic diseases. ResMed comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, ResMed improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.
Segmentation Overview:
By type, Nasal Cannulas segment accounted for the largest share of market in 2021.
Application Overview:
By application, the Hospitals segment occupied the biggest share from 2017 to 2022.
This report elaborates on the market size, market characteristics, and market growth of the High-flow Nasal Cannula industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of High-flow Nasal Cannula. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global High-flow Nasal Cannula Market Report Include:
Market Size Estimates: High-flow Nasal Cannula market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: High-flow Nasal Cannula market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the High-flow Nasal Cannula market
Segment Market Analysis: High-flow Nasal Cannula market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: High-flow Nasal Cannula market situations and prospects in major and top regions and countries
High-flow Nasal Cannula Market
Competitive Landscape
and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product/service profile and recent development/updates, etc.High-flow Nasal Cannula Industry Chain: High-flow Nasal Cannula market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
High-flow Nasal Cannula Industry News, Policies by regions
High-flow Nasal Cannula Industry Porters Five Forces Analysis
Key players in the global High-flow Nasal Cannula market are covered in Chapter 2:
Salter Labs
Teleflex Incorporated
TNI Medical AG
Flexicare Medical Limited
Fisher & Paykel Healthcare
ResMed
Great Group Medical
Vyaire Medical
Hamilton Medical
Koninklijke Philips
Vapotherm
In Chapter 6 and Chapter 9, on the basis of types, the High-flow Nasal Cannula market from 2018 to 2028 is primarily split into:
Air/Oxygen Blender
Nasal Cannulas
Active Humidifier
Single Heated Tube
Others
In Chapter 7 and Chapter 10, on the basis of applications, the High-flow Nasal Cannula market from 2018 to 2028 covers:
Hospitals
Clinics
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global High-flow Nasal Cannula market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the High-flow Nasal Cannula industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of High-flow Nasal Cannula market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the High-flow Nasal Cannula industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on High-flow Nasal Cannula market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the High-flow Nasal Cannula market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed High-flow Nasal Cannula market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
